Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Celldex is developing targeted therapeutics to address devastating diseases for which available treatments are inadequate. There pipeline is built from a proprietary portfolio of antibodies and immunomodulators used alone and in strategic combinations to create novel, disease-specific therapies that induce, enhance or suppress the body's immune response
Recent Articles
- Exploring Cultural Connections Between Ancient Civilizations
- First Insight and M&S: Transforming Retail Experience Together
- The O2 Achieves Record Ticket Sales and Unforgettable Events
- Il Lanificio Expands European Footprint with New Store Openings
- Unpacking the Growth of the Application Transformation Market
- Hunton Andrews Kurth Expands Energy Team with Top Lawyers
- Exciting Partnership Between Xsolla and iBLOXX for Web3 Games
- Enhancing the Gaming Experience in Poland with Xsolla and Mastercard
- DTR Unveils Innovative Payment Technology for Global Transactions
- Universities 100 Mile Relay Finals: A Celebration of Unity and Sport
- Negal Engineering AG: Innovating for a Sustainable Future
- China Airlines Embarks on a Digital Transformation Journey
- Enfinity Global Secures Major Financing for Renewable Projects in Italy
- Amwins Global Risks Appoints Gabriel Ewing to Lead Growth
- New Leadership at New Oriental: Welcoming Dr. Yue Zhuge
- Enfinity Global Secures Major Financing for Solar Projects
- Amwins Global Risks Strengthens Team with New Expert Leadership
- British Army Tests RTX's Advanced Laser Weapon System
- Economic Predictions Amid New Policies: California and Beyond
- Fancy Sprinkles Teams Up with Walmart for Holiday Offerings
- Unforgettable Live Events in the UK: A 2024 Retrospective
- Martela Adjusts 2024 Financial Forecast Amid Market Growth
- EQT Life Sciences Enhances Investment in Noema Pharma's Success
- Sobi's EGM Insights: New Board Chair to Lead Forward
- Saudi Arabia's COP16: Urgent Call Against Dryland Expansion
- Major Developments at Sobi's Extraordinary General Meeting
- Datamaran and Deloitte Join Forces to Enhance ESG Frameworks
- Ariceum and NorthStar Partner for Ac-225 Radioisotope Supply
- Key Financial Dates for TCM Group A/S's Upcoming Year
- Microip Soars After Listing: Next-Level IC Design Innovations
- Growing Demand for Collectibles: A $484.6 Billion Industry Ahead
- China's Commitment to Economic Growth and Global Cooperation
- Weichai Powers International Growth Through Innovation
- Shifting Perspectives on Private Capital: Insights for 2025
- Empowering Start-Ups: SimScale Partners with PTC Onshape
- Revolutionizing IoT: STMicroelectronics Launches New Modules
- Surge in Sexual Harassment Cases Among UK Healthcare Workers
- Kalmar Expands Operations with New Equipment for Boluda
- Banyan Software Welcomes Moritz Franz as New M&A Director
- EDF Increases 2024 Nuclear Power Generation Estimates Significantly
- Svitzer Expands Fleet with Four New TRAnsverse Tugs Orders
- Noema Pharma Secures CHF 130 Million in Series B Financing
- 4CRisk.ai Earns Spot on RegTech100 Most Innovative List
- JobRad Leasing’s Growth Through Innovative Financing Solutions
- Solstice Labs Launches Staking Services in Groundbreaking Move
- Streamlined Contract Management: Oneflow Enhances Efficiency
- Syncron Revolutionizes Audit Processes for Enhanced Compliance
- RFOptic Introduces Efficient RFoF Ultra Series for High Frequencies
- Changan Automobile's Journey: A Digital Transformation Tale
- Macao's Strategic Integration into National Development Plans